We would love to hear your thoughts about our site and services, please take our survey here.
The point is that the placing was prior to any vaccine release. Hugely difference position without them!
Thanks for sharing.
Meeting last week in US with Avion CEO and they wanted to participate and invest in the portolio. This is a recognition of the confidence felt.
PK study not quite complete but CIDP P3 pivotal study will commence next year as well as the lupus study. "Potential to get to market sooner than for lupus as the way it works".
Agreed. Those involved / in the know are investing. Must be a good sign that things are looking good!
No sure if only taking large buys, but not letting me!?
Apologies if already shared
Should i have been sent log in details as I'm a shareholder? Can't access using the link??
Was all very quiet. I asked a few questions, some of which answered.
Sounded quite positive re Avion partnership and starting phase 3, but approx 2 years to complete!?
So to confirm, we are in same position as last week ie awaiting FDA update and SP just dropping due to impatience.
Must admit I'm getting bored of waiting!
Has anyone seen this? If so, how do you register?
Anything interesting? Share price doesn't suggest so? Many thanks in advance
What do we think? Rumbled?
She does have good insight at times and thinks outside the box though......
Many thanks. Very helpful. No mention of "by mouth" anywhere that I can find! ;}
Can't see one? Can anyone post here please?
Can't see an reason.what's happened?
How do you sign up for this?
Can't find any links.
What do you think will be outcome for tomorrow's sp? Thanks
Agree. Patients need to be recruited as they arrive in hospital. I assume he meant that they have all sites and investigators ready to recruit when the go ahead is given. Right now should be very easy to recruit 10 patients per UK site in a matter of days. Definately the time for access to the patient group required in most parts on the world. If had started in the summer would have been different so that's a positive we delay until now.
Agree. Patients need to be recruited as they arrive in hospital. I assume he meant that they have all sites and investigators ready to recruit when the go ahead is given. Right now should be very easy to recruit 10 patients per UK site in a matter of days. Definately the time for access to the patient group required in most parts on the world. If had started in the summer would have been different so that's a positive we delay until now.
Yes, correct. The other agents used were long established agents rather than an unlicensed drug in development. He said also that therapy with the nebuliser more complex in a trial. I was satisfied with explanation, as a pharmacist.
A contraindication is a particular condition under which the manufacturer states that an agent should not be used eg hypersensitivity
to active ingredient, in liver disease, in pregnancy etc.
It is not usually stated that in combination with another agent (ie with dexameth) that a drug would be contraindicated. This is more likely to come under a drug-drug interaction and is usually manageable in combination.
In webinar this week RM started that dexameth suppresses IFN beta ptoduction and that SNG001 is a "Happy companion to dex". No way it will be contraindicated in combo.
Anyone know?
Have we dropped because not ours?